SCHEMBL984520

SCHEMBL984520

Cc1ccc(OCC2CC2)c(-c2ncnc3c(C(=O)NC4CCN(C(=O)C5(O)CC5)CC4)c[nH]c23)c1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MDM4 O15151 1/20 0.37
KDM2B Q8NHM5 1/20 0.35
KDM4C Q9H3R0 1/20 0.35
MAP3K6 O95382 3/20 0.34
MAP3K5 Q99683 3/20 0.34
JAK3 P52333 5/20 0.33
PAK1 Q13153 2/20 0.33
CNR2 P34972 1/20 0.32
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 1/20 0.32
KMT2A Q03164 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
ADORA2A P29274 1/20 0.32
ADORA1 P30542 1/20 0.32
BTK Q06187 1/20 0.32
LMNA P02545 1/20 0.32
GLA P06280 1/20 0.32
HSD17B10 Q99714 1/20 0.32
CTDSP1 Q9GZU7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL985286 0.91 KMT2A (0.37) MDM4JAK3PAK1MEN1KMT2A
SCHEMBL981807 0.90 MDM4 (0.38) MDM4KDM2BKDM4CMAP3K6MAP3K5
SCHEMBL985635 0.90 BTK (0.37) MDM4KDM2BKDM4CADORA2AADORA1
SCHEMBL981263 0.89 MDM4 (0.37) MDM4KDM2BKDM4CMAP3K6MAP3K5
SCHEMBL984309 0.89 ALDH1A1 (0.43) MEN1ALDH1A1KMT2AL3MBTL1LMNA
SCHEMBL983643 0.88 MDM4 (0.36) MDM4KDM2BKDM4CMAP3K6MAP3K5
SCHEMBL985561 0.88 BTK (0.42) MDM4KDM2BKDM4CMAP3K6MAP3K5
SCHEMBL981476 0.87 MDM4 (0.36) MDM4JAK3PAK1KMT2A
SCHEMBL985264 0.87 MAPT (0.43) MEN1ALDH1A1KMT2AL3MBTL1BTK
SCHEMBL982310 0.86 MAP3K5 (0.37) MDM4MAP3K6MAP3K5JAK3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110021479-A1 PYRROLOPYRIMIDINECARBOXAMIDES NYCOMED GMBH (DE) 2011-01-27 US claimed
US-20110021479-A1 PYRROLOPYRIMIDINECARBOXAMIDES NYCOMED GMBH (DE) 2011-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110021479-A1 PYRROLOPYRIMIDINECARBOXAMIDES PDE5A, PDE3A, PDE2A MDM4 2898/4885KDM2B 831/4885KDM4C 599/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.